A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809
NCT05214677 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 38
Last updated 2022-01-31
Summary
Randomized, Open-label, Oral, Single-dose, two-Sequence, four-Period, crossover study
Conditions
- Osteoarthritis
- Rheumatoid Arthritis
- Back Pain
- Acute Upper Respiratory Tract Infection
Interventions
- DRUG
-
DW1809
pelubiprofen 30mg
- DRUG
-
DW1809-1
pelubiprofen 30mg (PELUBI tab.)
Sponsors & Collaborators
-
Daewon Pharmaceutical Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-08-15
- Primary Completion
- 2020-09-07
- Completion
- 2020-09-07
Countries
- South Korea
Study Locations
More Related Trials
-
A Multiple Dose Study of DWP05195 in Healthy Adult Subjects
NCT01094834 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Safety/Tolerability Profiles of DA-2811 in Healthy Subjects (DA-2811)
NCT04938752 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers
NCT04003441 ·Status: UNKNOWN ·Phase: PHASE1
-
To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003
NCT04592835 ·Status: UNKNOWN ·Phase: PHASE1
-
Phamacokinetics and Safety Profiles of DA-1229_01 5/1000mg in Healthy Subjects at Fasting State
NCT05739903 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety and Pharmacokinetics of DWJ1439, DWJ1464, DWC202003 or DWC202004 in Healthy Volunteers
NCT04477369 ·Status: UNKNOWN ·Phase: PHASE1
-
DWP05195 in Healthy Adult Male Volunteers
NCT00969787 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fed State
NCT07342062 ·Status: COMPLETED ·Phase: PHASE1
-
A Single Dose Study of DWP10292 in Healthy Male Subjects
NCT01423526 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Compare and Evaluate the Safety, Tolerability and Pharmacokinetics Between DA-5223 and DA-5223-R in Healthy Adult Subjects
NCT07007533 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Japanese, Caucasian and Korean
NCT03574415 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 Study of Daewon-ES(B) & Megace in Healthy Male Volunteers Under Fed Condition
NCT01589562 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety, Tolerability, PK, and PD of DWP213388 After SAD and MAD Administration in Healthy Adult Subjects
NCT05607589 ·Status: WITHDRAWN ·Phase: PHASE1
-
To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P59 in Healthy Subjects
NCT04525079 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety/Tolerability, Pharmacokinetics, and Pharmacodynamics After Intravenous DWJ1521 Administration in Healthy Adult Volunteers
NCT04827472 ·Status: UNKNOWN ·Phase: PHASE1
-
Clinical Trial of Comparing DA-5222 Single-administration and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult Subjects
NCT06993181 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Study to Evaluate the Safety/Tolerability, PK and PD After Intravenous DWJ1521 Administration in Healthy Volunteers
NCT06508645 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the PK, PD, Safety and Drug Tolerance in Healthy Volunteers
NCT05433844 ·Status: COMPLETED ·Phase: PHASE1
-
To Assess the Safety, Tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) Which is the Treatment of COVID-19 in Healthy Volunteers.
NCT04749173 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Evaluate Pharmacokinetics of Daewon DW-ES(A) 625mg/5ml, Daewon DW-ES(B) 625mg/5ml and Megace 800mg/20ml in Healthy Male Volunteers Under Fed Condition
NCT01383330 ·Status: UNKNOWN ·Phase: PHASE1
-
Study to Determine Safety, Tolerability and Pharmacokinetics, of SCO-120 in Healthy Male and Post-menopausal Female Subjects
NCT04242953 ·Status: COMPLETED ·Phase: PHASE1
-
A Single Dose Study of Debio 1450 in Healthy Subjects
NCT02162199 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics of KD101 in Healthy Male Subjects
NCT01979380 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of ACE-2494 in Healthy Subjects
NCT03478319 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety, Tolerability, and Pharmacokinetic Study of GDC-3280 in Healthy Participants
NCT02471859 ·Status: COMPLETED ·Phase: PHASE1